References
- Jones KL. Smith’s recognizable patterns of human malformation. 7th ed. Philadelphia: Elsevier Saunders; 2013.
- Cuckle H, Benn P, Wright D. Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters. Semin Perinatol. 2005;29(4):252–257.
- Malone FD, Canick JA, Ball RH, et al. First-trimester or second-trimester screening, or both, for Down’s syndrome. N Engl J Med. 2005;353(19):2001–2011.
- Spencer K, Bindra R, Nicolaides KH. Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy. Prenat Diagn. 2003;23(10):851–855.
- Shohat M, Frimer H, Shohat-Levy V, et al. Prenatal diagnosis of Down syndrome: ten year experience in the Israeli population. Am J Med Genet A. 2003;122A(3):215–222.
- Leung TY, Spencer K, Leung TN, et al. Higher median levels of free beta-hCG and PAPP-A in the first trimester of pregnancy in a Chinese ethnic group. Implication for first trimester combined screening for Down’s syndrome in the Chinese population. Fetal Diagn Ther. 2006;21(1):140–143.
- Kagan KO, Wright D, Spencer K, et al. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2008;31(5):493–502.
- Ardawi MS, Nasrat HA, Rouzi AA, et al. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10–13(+6) weeks in relation to co-variables in pregnant Saudi women. Prenat Diagn. 2007;27(4):303–311.
- Manotaya S, Zitzler J, Li X, et al. Effect of ethnicity on first trimester biomarkers for combined trisomy 21 screening: results from a multicenter study in six Asian countries. Prenat Diagn. 2015;35(8):735–740.
- Bryant-Greenwood PK, O’Brien JE, Huang X, et al. Maternal weight differences do not explain ethnic differences in biochemical screening. Fetal Diagn Ther. 1998;13(1):46–48.
- Watt HC, Wald NJ, Smith D, et al. Effect of allowing for ethnic group in prenatal screening for Down’s syndrome. Prenat Diagn. 1996;16(8):691–698.
- Luewan S, Sirichotiyakul S, Yanase Y, et al. Median levels of serum biomarkers of fetal Down syndrome detected during the first trimester among pregnant Thai women. Int J Gynecol Obstet. 2012;117(2):140–143.
- Lee JH, Park Y, Suh B, et al. Performance characteristics of the UniCel DxI 800 immunoassay for the maternal serum quadruple test, including median values for each week of gestation, in Korean women. Korean J Lab Med. 2010;30(2):126–132.
- Wang YY, Luo J, Zhu MW, et al. Second-trimester double or triple screening for Down syndrome: a comparison of Chinese and Caucasian populations. Int J Gynecol Obstet. 2006;94(1):67–72.
- Brooks K, Chik L, O’Brien JE, et al. Variability of adjustments to indices in determining patient risk in biochemical screening. Fetal Diagn Ther. 1999;14(1):41–46.
- O’Brien JE, Dvorin E, Drugan A, et al. Race-ethnicity-specific variation in multiple-marker biochemical screening: alpha-fetoprotein, hCG, and estriol. Obstet Gynecol. 1997;89(3):355–358.